The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Atypical Hyperplasia of the Breast — Risk Assessment and Management Options
Open accessAbstract
The criteria for inclusion in the table were a central pathological review and the use of the criteria of David Page and colleagues for the diagnosis of atypical hyperplasia.9 CI denotes confidence interval.† The study was a retrospective cohort study involving women who had excisional biopsies performed during the period 1950 -1968.The median duration of follow-up was 17 years.Risk estimates are for invasive breast cancer only.‡ The study was a retrospective cohort study involving women who had excisional biopsies, core biopsies, or both performed during the period 1967-2001.The median duration of follow-up was 12.1 years.Risk estimates are for both invasive and in situ breast cancer (19% of cases were in situ).The numbers of patients in subcategories may not add to the total because information was missing for some patients.§ A strong family history was defined as at least one first-degree relative with breast cancer before 50 years of age or two or more relatives with breast cancer, with at least one being a first-degree relative.A weak family history was defined as any lesser degree of family history.¶ The study was a retrospective cohort study involving women who had biopsies performed during the period 1981-1994.The duration of follow-up was not specified.Risk estimates are for both invasive and in situ breast cancer (20% of cases were in situ).‖ The study was a nested case-control study.The type of breast cancer (i.e., invasive or in situ) evaluated for the risk estimates was not specified.** The study was a nested case-control study; risk estimates are for both invasive and in situ breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Self-citationA breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
Self-citation
Cited by
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
Elmore, J. G., Longton, G. M., Carney, P. A., Geller, B. M., Onega, T., Tosteson, A. N. A., Nelson, H. D., Pepe, M. S., Allison, K. H., Schnitt, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1405 · Cited by 751
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002158 · Cited by 258
Metadata
- Authors
- Hartmann, L. C., Degnim, A. C., Santen, R. J., Dupont, W. D., & Ghosh, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-01-01
- Volume
- 372
- Issue
- 1
- Pages
- 78-89
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2049869682
- Cited by
- 366
- References
- 57
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atypical Hyperplasia of the Breast — Risk Assessment and Management Options. https://app.cochat.ai/papers/10.1056/nejmsr1407164
- The paper
- Hartmann, L. C., Degnim, A. C., Santen, R. J., Dupont, W. D., & Ghosh, K. (2015). Atypical Hyperplasia of the Breast — Risk Assessment and Management Options. New England Journal of Medicine. https://doi.org/10.1056/nejmsr1407164
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
